EU Pharma Calls For Better Metrics On True Impact Of Clinical Trial Disclosure
Executive Summary
European pharmaceutical industry group, EFPIA, says it is committed to supporting clinical trial transparency, but wants greater clarity on how disclosed data are effectively contributing to public health improvements so that investments can be prioritized in areas providing the greatest benefit.